Manufacture of pharmaceutical preparations
PALLA PHARMA NORWAY AS
Revenue 2024
NOK 213.2m
Operating profit
NOK 19.7m
Equity
NOK 52.6m
Incorporated
2016
Employees
72
Share capital
NOK 3.6m
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 213.2m | |
| Total operating costs | 193.5m | |
| Operating profit (EBIT) | 19.7m | |
| Net financial items | −6.3m | |
| Profit for the year | 13.4m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 168.1m | |
| of which current assets | 96.3m | |
| Equity | 52.6m | |
| Total liabilities | 115.5m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.